184 related articles for article (PubMed ID: 30472805)
1. Physico-chemical stability of Plasma-Lyte 148® and Plasma-Lyte 148® + 5% Glucose with eight common intravenous medications.
Dawson R; Wignell A; Cooling P; Barrett D; Vyas H; Davies P
Paediatr Anaesth; 2019 Feb; 29(2):186-192. PubMed ID: 30472805
[TBL] [Abstract][Full Text] [Related]
2. Plasma-Lyte 148 and Plasma-Lyte 148 + 5% glucose compatibility with commonly used critical care drugs.
Hammond S; Wignell A; Cooling P; Barrett DA; Davies P
Intensive Care Med Exp; 2020 Jun; 8(1):25. PubMed ID: 32577941
[TBL] [Abstract][Full Text] [Related]
3. Sodium reduction during cardiopulmonary bypass: Plasma-Lyte 148 versus trial fluid as pump primes.
Morgan TJ; Presneill JJ; Davies PG; Power G; Venkatesh B
Crit Care Resusc; 2015 Dec; 17(4):263-7. PubMed ID: 26640062
[TBL] [Abstract][Full Text] [Related]
4. Is the infusion of Plasma-Lyte 148 and 5% Glucose into peripheral veins really problematic?
Fihlman M; Kataja JT
Acta Paediatr; 2018 Nov; 107(11):2026-2027. PubMed ID: 29953656
[No Abstract] [Full Text] [Related]
5. Characterisation of aluminium release by the enFlow® fluid-warming system in crystalloids and blood products.
Taylor MH; Choi D; Fitzpatrick SM; Gunn KN
Anaesthesia; 2019 Nov; 74(11):1374-1380. PubMed ID: 31066048
[TBL] [Abstract][Full Text] [Related]
6. Galactomannan antigenemia after infusion of gluconate-containing Plasma-Lyte.
Petraitiene R; Petraitis V; Witt JR; Durkin MM; Bacher JD; Wheat LJ; Walsh TJ
J Clin Microbiol; 2011 Dec; 49(12):4330-2. PubMed ID: 21976760
[TBL] [Abstract][Full Text] [Related]
7. Acid-base effects of a bicarbonate-balanced priming fluid during cardiopulmonary bypass: comparison with Plasma-Lyte 148. A randomised single-blinded study.
Morgan TJ; Power G; Venkatesh B; Jones MA
Anaesth Intensive Care; 2008 Nov; 36(6):822-9. PubMed ID: 19115651
[TBL] [Abstract][Full Text] [Related]
8. Multicentre randomised controlled trial: protocol for Plasma-Lyte Usage and Assessment of Kidney Transplant Outcomes in Children (PLUTO).
Hayes W; Laing E; Foley C; Pankhurst L; Thomas H; Hume-Smith H; Marks S; Kessaris N; Bryant WA; Spiridou A; Wray J; Peters MJ
BMJ Open; 2022 Mar; 12(3):e055595. PubMed ID: 35288387
[TBL] [Abstract][Full Text] [Related]
9. Overview of the study protocols and statistical analysis plan for the Saline versus Plasma-Lyte 148 for Intravenous Fluid Therapy (SPLIT) research program.
Reddy SK; Young PJ; Beasley RW; Mackle DM; McGuinness SP; McArthur CJ; Henderson SJ; Weinberg L; French CJ; Orford NR; Bailey MJ; Bellomo R
Crit Care Resusc; 2015 Mar; 17(1):29-36. PubMed ID: 25702759
[TBL] [Abstract][Full Text] [Related]
10. The effects of 0.9% saline versus Plasma-Lyte 148 on renal function as assessed by creatinine concentration in patients undergoing major surgery: A single-centre double-blinded cluster crossover trial.
Weinberg L; Li MH; Churilov L; Macgregor C; Garrett K; Eyles J; Bellomo R
PLoS One; 2021; 16(5):e0251718. PubMed ID: 34010324
[TBL] [Abstract][Full Text] [Related]
11. A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO).
Hayes WN; Laing E; Brown R; Silsby L; Smith L; Thomas H; Kaloyirou F; Sharma R; Griffiths J; Hume-Smith H; Marks SD; Kessaris N; Christian M; Dudley J; Shenoy M; Malina M; Muorah M; Ware N; Yadav P; Reynolds B; Bryant W; Spiridou A; Wray J; Peters MJ
Kidney Int; 2024 Feb; 105(2):364-375. PubMed ID: 37914088
[TBL] [Abstract][Full Text] [Related]
12. Effect of 0.9% Saline or Plasma-Lyte 148 as Crystalloid Fluid Therapy in the Intensive Care Unit on Blood Product Use and Postoperative Bleeding After Cardiac Surgery.
Reddy SK; Bailey MJ; Beasley RW; Bellomo R; Mackle DM; Psirides AJ; Young PJ
J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1630-1638. PubMed ID: 28774642
[TBL] [Abstract][Full Text] [Related]
13. 0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU-a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial.
Raman S; Schibler A; Marsney RL; Trnka P; Kennedy M; Mattke A; Gibbons K; Schlapbach LJ
Trials; 2021 Jul; 22(1):427. PubMed ID: 34217337
[TBL] [Abstract][Full Text] [Related]
14. Exploring a case of incompatibility in a complex regimen containing Plasma-Lyte 148 in the pediatric intensive care.
Nilsson N; Nguyen V; Nezvalova-Henriksen K; Tho I
Paediatr Anaesth; 2023 Mar; 33(3):211-218. PubMed ID: 36336980
[TBL] [Abstract][Full Text] [Related]
15. Effect of 0.9% NaCl compared to plasma-lyte on biomarkers of kidney injury, sodium excretion and tubular transport proteins in patients undergoing primary uncemented hip replacement - a randomized trial.
Østergaard AM; Jørgensen AN; Bøvling S; Ekeløf NP; Mose FH; Bech JN
BMC Nephrol; 2021 Mar; 22(1):111. PubMed ID: 33771116
[TBL] [Abstract][Full Text] [Related]
16. Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets.
Floy BJ; Royko CG; Fleitman JS
Am J Hosp Pharm; 1990 May; 47(5):1097-100. PubMed ID: 2337102
[TBL] [Abstract][Full Text] [Related]
17. Comparison of saphenous vein graft relaxation between Plasma-Lyte solution and normal saline solution.
Sanchez AM; Wooldridge TA; Boerboom LE; Olinger GN; Almassi GH; Rusch NJ
J Thorac Cardiovasc Surg; 1994 Jun; 107(6):1445-53. PubMed ID: 8196386
[TBL] [Abstract][Full Text] [Related]
18. Plasma acetate, gluconate and interleukin-6 profiles during and after cardiopulmonary bypass: a comparison of Plasma-Lyte 148 with a bicarbonate-balanced solution.
Davies PG; Venkatesh B; Morgan TJ; Presneill JJ; Kruger PS; Thomas BJ; Roberts MS; Mundy J
Crit Care; 2011; 15(1):R21. PubMed ID: 21235742
[TBL] [Abstract][Full Text] [Related]
19. Saline versus Plasma-Lyte A in initial resuscitation of trauma patients: a randomized trial.
Young JB; Utter GH; Schermer CR; Galante JM; Phan HH; Yang Y; Anderson BA; Scherer LA
Ann Surg; 2014 Feb; 259(2):255-62. PubMed ID: 23732264
[TBL] [Abstract][Full Text] [Related]
20. A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study.
Reddy SK; Bailey MJ; Beasley RW; Bellomo R; Henderson SJ; Mackle DM; McArthur CJ; Mehrtens JE; Myburgh JA; McGuinness SP; Psirides AJ; Young PJ
Crit Care Resusc; 2014 Dec; 16(4):274-9. PubMed ID: 25437221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
